查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1965456

替代蛋白市场－全球产业规模、份额、趋势、机会、预测：按产品类型、应用、地区和竞争格局划分，2021-2031年

Alternative Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球替代蛋白市场预计将从 2025 年的 169.8 亿美元成长到 2031 年的 270.4 亿美元，复合年增长率为 8.06%。

这些食品被定义为以植物来源原料、发酵製程或动物细胞培养技术生产的食品，旨在复製传统肉类的感官和营养特性。推动其成长的关键因素包括应对气候变迁的迫切挑战、全球为确保长期粮食安全而对高效资源利用的需求，以及消费者对多样化蛋白质来源健康益处的日益关注。受此发展动能影响，根据良好食品研究所（GFI）预测，到2024年，全球植物来源肉类和乳製品替代品的销售额将达到286亿美元。

市场概览
预测期 2027-2031
市场规模：2025年 169.8亿美元
市场规模：2031年 270.4亿美元
复合年增长率：2026-2031年 8.06%
成长最快的细分市场 动物饲料
最大的市场 北美洲

然而，该产业面临许多挑战，主要源自于严峻的投资环境，限制了扩大生产营运所需的资金。资金筹措困难阻碍了企业发展实现技术规模经济所需的必要基础设施，导致其在价格上难以与传统动物产品竞争。根据良好食品研究所（Good Food Institute）预测，到2024年，替代蛋白产业的总资金筹措额仅11亿美元。投资资本的萎缩是实现快速产业扩张、确保大众市场渗透的关键障碍。

市场驱动因素

挤压和微发酵技术的突破对于克服阻碍替代蛋白广泛应用的质地和成本障碍至关重要。具体而言，高水分挤压技术的创新将能够生产出类似动物肌肉纤维质地的块状肉状替代产品，而微发酵技术则能够实现血红素和酪蛋白等功能性成分的规模化生产。随着这些技术从实验室规模的原型走向工业化生产，它们对于实现与传统肉类的价格竞争力至关重要。根据良好食品研究所发布的《2024年产业趋势：发酵》报告，预计到2024年至少将有17家发酵设施投入营运或正在规划建设中，这表明儘管面临经济挑战，全球生物製造能力仍将强劲扩张。这将直接有助于供应链的稳定性和成本的降低。

同时，政府的支持政策和法规结构正在为市场合法性和永续研发创造稳定的环境。各国政府日益认识到替代蛋白是提升国家粮食安全和实现气候目标的重要战略资产，这促使公共投资和私人奖励显着增加，以支持开放取用的研究。根据良好食品研究所发布的《2024年全球政策状况》报告，到2024年，世界各国政府将在该领域投资约5.1亿美元。公共资本的涌入有助于降低早期创新阶段的风险，并透过补充私人资金加速商业化进程。这些驱动因素的成功也体现在消费者的行为中；据良好食品研究所称，到2025年，59%的美国家庭将购买植物来源食品，这表明供应增加和製度支持正在有效地推动市场渗透。

市场挑战

投资限制严重阻碍了全球替代蛋白市场的发展，因为其所需的资本不足以扩大生产规模。后期融资管道的匮乏使得製造商无法承担建造大规模生产设施所需的巨额支出。基础设施扩张的困难阻碍了企业实现降低单位成本所需的技术规模经济。因此，替代蛋白产品被迫维持高于传统肉品的价格，这不仅阻碍了其在消费者中的广泛普及，也限制了其市场渗透范围，使其仅限于特定细分市场。

近期数据显示，植物蛋白产业的资金大幅下降，凸显了资金筹措资金筹措的严重性。根据良好食品研究所（Good Food Institute）预测，到2024年，对植物蛋白公司的投资将降至3.09亿美元，年比大幅下降64%。可用资金的急剧减少迫使许多公司暂停或取消了原定的工厂扩建计划。因此，该行业正艰难地从试点规模的生产过渡到工业化规模的生产，而工业化生产对于实现价格竞争力并与传统畜牧业有效竞争至关重要。

市场趋势

将植物来源成分与发酵或培养成分结合的混合产品的兴起，正成为解决弹性素食消费者感官限制的一种切实可行的策略。透过组合不同的蛋白质来源，製造商可以提供纯植物来源配方难以实现的风味和口感，同时与完全培养的替代品相比，还能优化成本结构和营养密度。这种综合方法正逐渐获得消费者的认可，成为那些对购买此类产品犹豫不决的消费者更容易接受的选择。根据Green Queen 2025年7月发表的一篇报导《全球调查：75%的消费者仍然对植物来源肉类和乳製品感兴趣》的文章，全球64%的消费者有兴趣购买使用混合蛋白质来源的混合肉类和乳製品。

同时，菌丝体和真菌蛋白平台的蓬勃发展正在打造一个可扩展的第三大生产基地，它不同于植物分离蛋白和培养肉。生物质发酵技术利用丝状真菌的纤维结构，自然模拟完整的肌肉组织，无需高压挤压和大规模的后处理工序。在消费者对加工程度较低的全食品的需求推动下，这项技术正迅速从试点阶段迈向大规模生产。根据AgFunderNews于2025年1月发表的报导报道，真菌蛋白生产商Meati Foods在2024年成功地将其零售分销网络同比增长了130%，并将菌丝体全切产品引入了数千家新的杂货店。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球替代蛋白市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品类型（植物蛋白、微生物蛋白、昆虫蛋白）
    • 按应用领域（食品和饮料、婴儿奶粉、临床营养、动物饲料、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美替代蛋白市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲替代蛋白市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区替代蛋白市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东与非洲替代蛋白市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲替代蛋白市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球替代蛋白市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Archer Daniels Midland Company
  • Cargill Inc.
  • Lightlife Foods, Inc.
  • Impossible Foods Inc.
  • International Flavors & Fragrances, Inc.
  • Ingredion Inc.
  • Kerry Group
  • Glanbia plc
  • Bunge Limited
  • Axiom Foods Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 26760

The Global Alternative Protein Market is projected to expand from USD 16.98 Billion in 2025 to USD 27.04 Billion by 2031, reflecting a compound annual growth rate of 8.06%. Defined as food products derived from plant-based ingredients, fermentation processes, or animal cell cultivation, these alternatives aim to replicate the sensory and nutritional characteristics of conventional meat. Growth is primarily driven by the urgent need to mitigate climate change and the global imperative for efficient resource usage to guarantee long-term food security, alongside increasing consumer recognition of the health advantages offered by diverse protein sources. Highlighting this momentum, the Good Food Institute reported that global sales of plant-based meat and dairy alternatives reached $28.6 billion in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 16.98 Billion
Market Size 2031USD 27.04 Billion
CAGR 2026-20318.06%
Fastest Growing SegmentAnimal Feed
Largest MarketNorth America

However, the sector encounters significant hurdles arising from a constrained investment climate that limits the capital needed to scale manufacturing operations. This scarcity of financial backing impedes companies from developing the necessary infrastructure to attain technological economies of scale, thereby delaying the achievement of price parity with traditional animal products. According to the Good Food Institute, total funding for the alternative protein sector amounted to just $1.1 billion in 2024. This contraction in investment capital creates a formidable barrier to the rapid industrial expansion essential for securing mass market adoption.

Market Driver

Technological breakthroughs in extrusion and precision fermentation are crucial for surmounting the texture and cost obstacles that currently impede the widespread adoption of alternative proteins. Specifically, innovations in high-moisture extrusion facilitate the production of whole-cut meat analogues that mimic the fibrous nature of animal muscle, while precision fermentation enables the scalable creation of functional ingredients such as heme and casein. As these technologies graduate from lab-scale prototypes to industrial manufacturing, they become vital for reaching price parity with conventional meat. Per the Good Food Institute's '2024 State of the Industry: Fermentation' report, at least 17 fermentation facilities were opened or announced in 2024, indicating strong growth in global biomanufacturing capacity despite economic challenges, which directly aids in stabilizing supply chains and lowering costs.

Simultaneously, supportive government policies and regulatory frameworks are creating a stable environment for market legitimacy and sustained research and development. Governments increasingly recognize alternative proteins as strategic assets for improving national food security and achieving climate goals, resulting in significant public investment in open-access research and private incentives. The Good Food Institute's '2024 State of Global Policy' report notes that governments globally committed approximately $510 million in new funding to the sector in 2024. This influx of public capital helps de-risk early-stage innovation and supplements private funding, speeding up commercialization. The success of these drivers is reflected in consumer behavior; according to the Good Food Institute, 59% of U.S. households purchased plant-based foods in the year prior to 2025, proving that better availability and institutional backing are effectively boosting market penetration.

Market Challenge

The restricted investment environment severely impedes the Global Alternative Protein Market by limiting the capital required to scale manufacturing operations. Without adequate access to late-stage growth funds, manufacturers are unable to finance the substantial expenditures necessary for constructing large-scale production facilities. This inability to expand infrastructure prevents companies from realizing the technical economies of scale essential for reducing unit costs. As a consequence, alternative protein products continue to command a price premium over conventional meat, which stalls mass consumer adoption and confines market penetration to niche demographics.

The severity of this financial contraction is underscored by recent data illustrating a sharp decline in funding. According to the Good Food Institute, investment in plant-based protein companies dropped to $309 million in 2024, marking a significant 64% decrease from the previous year. This drastic reduction in available capital compels many firms to suspend or cancel intended facility expansions. Consequently, the industry faces difficulties in transitioning from pilot-scale operations to the industrial-grade output needed to achieve price parity and compete effectively against the traditional animal agriculture sector.

Market Trends

The rise of hybrid products that merge plant-based ingredients with fermentation-derived or cultivated components is becoming a practical strategy to address sensory limitations for flexitarian consumers. By combining various protein sources, manufacturers can offer enhanced taste and texture profiles that are difficult to achieve with pure plant-based formulations, while also optimizing cost structures and nutritional density relative to fully cultivated alternatives. This integrated approach is gaining traction as a familiar option for hesitant buyers; a July 2025 article by Green Queen titled 'Global Survey: 75% of Consumers Still Interested in Plant-Based Meat & Dairy' reported that 64% of global consumers are interested in purchasing blended meat and dairy products featuring mixed protein sources.

In parallel, the growth of mycelium and fungi-based protein platforms is creating a scalable third production pillar, separate from plant isolates and cultivated meat. Biomass fermentation leverages filamentous fungi to naturally mimic the fibrous structure of whole-cut muscle tissue, eliminating the need for heavy extrusion or extensive downstream processing. Driven by consumer demand for less processed, whole-food options, this technology is moving quickly from pilot demonstrations to mass availability. As reported by AgFunderNews in January 2025, in the article 'Meati expands distribution, anticipates positive gross margins by the year end,' fungi-based manufacturer Meati Foods expanded its retail distribution by 130% year-over-year in 2024, successfully introducing its mycelium-based whole-cut products to thousands of new grocery outlets.

Key Market Players

  • Archer Daniels Midland Company
  • Cargill Inc.
  • Lightlife Foods, Inc.
  • Impossible Foods Inc.
  • International Flavors & Fragrances, Inc.
  • Ingredion Inc.
  • Kerry Group
  • Glanbia plc
  • Bunge Limited
  • Axiom Foods Inc.

Report Scope

In this report, the Global Alternative Protein Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Alternative Protein Market, By Product Type

  • Plant Proteins
  • Microbe-based Protein
  • Insect Protein

Alternative Protein Market, By Application

  • Food & Beverages
  • Infant Formulations
  • Clinical Nutrition
  • Animal Feed
  • Others

Alternative Protein Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Alternative Protein Market.

Available Customizations:

Global Alternative Protein Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Alternative Protein Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Plant Proteins, Microbe-based Protein, Insect Protein)
    • 5.2.2. By Application (Food & Beverages, Infant Formulations, Clinical Nutrition, Animal Feed, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Alternative Protein Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Alternative Protein Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Alternative Protein Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Alternative Protein Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application

7. Europe Alternative Protein Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Alternative Protein Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Alternative Protein Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Alternative Protein Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Alternative Protein Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Alternative Protein Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Alternative Protein Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Alternative Protein Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Alternative Protein Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Alternative Protein Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Alternative Protein Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Alternative Protein Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Alternative Protein Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Alternative Protein Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Alternative Protein Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Alternative Protein Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application

10. South America Alternative Protein Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Alternative Protein Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Alternative Protein Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Alternative Protein Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Alternative Protein Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Archer Daniels Midland Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cargill Inc.
  • 15.3. Lightlife Foods, Inc.
  • 15.4. Impossible Foods Inc.
  • 15.5. International Flavors & Fragrances, Inc.
  • 15.6. Ingredion Inc.
  • 15.7. Kerry Group
  • 15.8. Glanbia plc
  • 15.9. Bunge Limited
  • 15.10. Axiom Foods Inc.

16. Strategic Recommendations

17. About Us & Disclaimer